These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
768 related articles for article (PubMed ID: 26979870)
61. Adenovirus-mediated transfer of human papillomavirus 16 E6/E7 antisense RNA and induction of apoptosis in cervical cancer. Hamada K; Shirakawa T; Gotoh A; Roth JA; Follen M Gynecol Oncol; 2006 Dec; 103(3):820-30. PubMed ID: 16908054 [TBL] [Abstract][Full Text] [Related]
62. Induction of apoptosis by chitosan/HPV16 E7 siRNA complexes in cervical cancer cells. Yang J; Li S; Guo F; Zhang W; Wang Y; Pan Y Mol Med Rep; 2013 Mar; 7(3):998-1002. PubMed ID: 23258711 [TBL] [Abstract][Full Text] [Related]
63. The E7 oncoprotein is translated from spliced E6*I transcripts in high-risk human papillomavirus type 16- or type 18-positive cervical cancer cell lines via translation reinitiation. Tang S; Tao M; McCoy JP; Zheng ZM J Virol; 2006 May; 80(9):4249-63. PubMed ID: 16611884 [TBL] [Abstract][Full Text] [Related]
64. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Holland D; Hoppe-Seyler K; Schuller B; Lohrey C; Maroldt J; Dürst M; Hoppe-Seyler F Cancer Res; 2008 Dec; 68(23):9964-72. PubMed ID: 19047178 [TBL] [Abstract][Full Text] [Related]
65. Biologic activity of oligonucleotides with polarity and anomeric center reversal. Tan TM; Kalisch BW; van de Sande JH; Ting RC; Tan YH Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):95-101. PubMed ID: 9593047 [TBL] [Abstract][Full Text] [Related]
66. Artificial microRNAs against the viral E6 protein provoke apoptosis in HPV positive cancer cells. Bonetta AC; Mailly L; Robinet E; Travé G; Masson M; Deryckere F Biochem Biophys Res Commun; 2015 Oct; 465(4):658-64. PubMed ID: 26241675 [TBL] [Abstract][Full Text] [Related]
67. A novel placental like alkaline phosphatase promoter driven transcriptional silencing combined with single chain variable fragment antibody based virosomal delivery for neoplastic cell targeting [corrected]. Khan I; Zakaria MK; Kumar M; Mani P; Chattopadhyay P; Sarkar DP; Sinha S J Transl Med; 2015 Aug; 13():254. PubMed ID: 26242403 [TBL] [Abstract][Full Text] [Related]
68. Human papillomavirus oncoproteins differentially modulate epithelial-mesenchymal transition in 5-FU-resistant cervical cancer cells. Vishnoi K; Mahata S; Tyagi A; Pandey A; Verma G; Jadli M; Singh T; Singh SM; Bharti AC Tumour Biol; 2016 Oct; 37(10):13137-13154. PubMed ID: 27449048 [TBL] [Abstract][Full Text] [Related]
69. Identification of E6/E7-Dependent MicroRNAs in HPV-Positive Cancer Cells. Honegger A; Schilling D; Sültmann H; Hoppe-Seyler K; Hoppe-Seyler F Methods Mol Biol; 2018; 1699():119-134. PubMed ID: 29086374 [TBL] [Abstract][Full Text] [Related]
70. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692 [TBL] [Abstract][Full Text] [Related]
71. Arsenic trioxide inhibits cell proliferation and human papillomavirus oncogene expression in cervical cancer cells. Wang H; Gao P; Zheng J Biochem Biophys Res Commun; 2014 Sep; 451(4):556-61. PubMed ID: 25117446 [TBL] [Abstract][Full Text] [Related]
73. Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter. Hirao N; Iwata T; Tanaka K; Nishio H; Nakamura M; Morisada T; Morii K; Maruyama N; Katoh Y; Yaguchi T; Ohta S; Kukimoto I; Aoki D; Kawakami Y Gynecol Oncol; 2019 Nov; 155(2):340-348. PubMed ID: 31477279 [TBL] [Abstract][Full Text] [Related]
74. Curcumin suppresses human papillomavirus oncoproteins, restores p53, Rb, and PTPN13 proteins and inhibits benzo[a]pyrene-induced upregulation of HPV E7. Maher DM; Bell MC; O'Donnell EA; Gupta BK; Jaggi M; Chauhan SC Mol Carcinog; 2011 Jan; 50(1):47-57. PubMed ID: 21061268 [TBL] [Abstract][Full Text] [Related]
75. Silencing of human papillomavirus (HPV) E6/E7 oncogene expression affects both the contents and the amounts of extracellular microvesicles released from HPV-positive cancer cells. Honegger A; Leitz J; Bulkescher J; Hoppe-Seyler K; Hoppe-Seyler F Int J Cancer; 2013 Oct; 133(7):1631-42. PubMed ID: 23526637 [TBL] [Abstract][Full Text] [Related]
76. Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells. Hamada K; Sakaue M; Alemany R; Zhang WW; Horio Y; Roth JA; Mitchell MF Gynecol Oncol; 1996 Nov; 63(2):219-27. PubMed ID: 8910631 [TBL] [Abstract][Full Text] [Related]
77. HPV-16 E6 and E7 oncogene expression is downregulated as a result of Mdm2 knockdown. Diaz D; Santander MA; Chavez JA Int J Oncol; 2012 Jul; 41(1):141-6. PubMed ID: 22504553 [TBL] [Abstract][Full Text] [Related]
78. Cytotoxic T lymphocytes elicited by dendritic cell-targeted delivery of human papillomavirus type-16 E6/E7 fusion gene exert lethal effects on CaSki cells. Wu XM; Liu X; Jiao QF; Fu SY; Bu YQ; Song FZ; Yi FP Asian Pac J Cancer Prev; 2014; 15(6):2447-51. PubMed ID: 24761845 [TBL] [Abstract][Full Text] [Related]
79. Systemic delivery of E6/7 siRNA using novel lipidic particles and its application with cisplatin in cervical cancer mouse models. Wu SY; Singhania A; Burgess M; Putral LN; Kirkpatrick C; Davies NM; McMillan NA Gene Ther; 2011 Jan; 18(1):14-22. PubMed ID: 20703312 [TBL] [Abstract][Full Text] [Related]
80. Fused toes homolog, a potential molecular regulator of human papillomavirus type 16 E6 and E7 oncoproteins in cervical cancer. D S P; Chaturvedi PK; Krishnamoorthy D; Seo YS; Thippana M; Park WY PLoS One; 2022; 17(4):e0266532. PubMed ID: 35421154 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]